{
    "title": "Parkinson's Research Act of 1997",
    "content": "SECTION 1. SHORT TITLE.\n\n    This Act may be cited as the ``Parkinson's Research Act of 1997''.\n\nSEC. 2. FINDING AND PURPOSE.\n\n    (a) Finding.--Congress finds that to take full advantage of the \ntremendous potential for finding a cure or effective treatment for \nParkinson's disease, the Federal investment in Parkinson's must be \nexpanded, as well as the coordination strengthened among the National \nInstitutes of Health research institutes.\n    (b) Purpose.--It is the purpose of this Act to provide for the \nexpansion and coordination of research regarding Parkinson's, and to \nimprove care and assistance for afflicted individuals and their family \ncaregivers.\n\nSEC. 3. PARKINSON'S RESEARCH.\n\n    Part B of title IV of the Public Health Service Act (42 U.S.C. 284 \net seq.) is amended by adding at the end the following:\n\n                         ``parkinson's disease\n\n    ``Sec. 409B. (a) In General.--The Director of NIH shall establish a \nprogram for the conduct and support of research and training with \nrespect to Parkinson's disease (subject to the extent of amounts \nappropriated under subsection (e)).\n    ``(b) Inter-Institute Coordination.--\n            ``(1) In general.--The Director of NIH shall provide for \n        the coordination of the program established under subsection \n        (a) among all of the national research institutes conducting \n        Parkinson's research.\n            ``(2) Conference.--Coordination under paragraph (1) shall \n        include the convening of a research planning conference not \n        less frequently than once every 2 years. Each such conference \n        shall prepare and submit to the Committee on Appropriations and \n        the Committee on Labor and Human Resources of the Senate and \n        the Committee on Appropriations and the Committee on Commerce \n        of the House of Representatives a report concerning the \n        conference.\n    ``(c) Morris K. Udall Research Centers.--\n            ``(1) In general.--The Director of NIH shall award Core \n        Center Grants to encourage the development of innovative \n        multidisciplinary research and provide training concerning \n        Parkinson's. The Director shall award not more than 10 Core \n        Center Grants and designate each center funded under such \n        grants as a Morris K. Udall Center for Research on Parkinson's \n        Disease.\n            ``(2) Requirements.--\n                    ``(A) In general.--With respect to Parkinson's, \n                each center assisted under this subsection shall--\n                            ``(i) use the facilities of a single \n                        institution or a consortium of cooperating \n                        institutions, and meet such qualifications as \n                        may be prescribed by the Director of the NIH; \n                        and\n                            ``(ii) conduct basic and clinical research.\n                    ``(B) Discretionary requirements.--With respect to \n                Parkinson's, each center assisted under this subsection \n                may--\n                            ``(i) conduct training programs for \n                        scientists and health professionals;\n                            ``(ii) conduct programs to provide \n                        information and continuing education to health \n                        professionals;\n                            ``(iii) conduct programs for the \n                        dissemination of information to the public;\n                            ``(iv) separately or in collaboration with \n                        other centers, establish a nationwide data \n                        system derived from patient populations with \n                        Parkinson's, and where possible, comparing \n                        relevant data involving general populations;\n                            ``(v) separately or in collaboration with \n                        other centers, establish a Parkinson's Disease \n                        Information Clearinghouse to facilitate and \n                        enhance knowledge and understanding of \n                        Parkinson's disease; and\n                            ``(vi) separately or in collaboration with \n                        other centers, establish a national education \n                        program that fosters a national focus on \n                        Parkinson's and the care of those with \n                        Parkinson's.\n            ``(3) Stipends regarding training programs.--A center may \n        use funds provided under paragraph (1) to provide stipends for \n        scientists and health professionals enrolled in training \n        programs under paragraph (2)(B).\n            ``(4) Duration of support.--Support of a center under this \n        subsection may be for a period not exceeding five years. Such \n        period may be extended by the Director of NIH for one or more \n        additional periods of not more than five years if the \n        operations of such center have been reviewed by an appropriate \n        technical and scientific peer review group established by the \n        Director and if such group has recommended to the Director that \n        such period should be extended.\n    ``(d) Morris K. Udall Awards for Excellence in Parkinson's Disease \nResearch.--The Director of NIH shall establish a grant program to \nsupport investigators with a proven record of excellence and innovation \nin Parkinson's research and who demonstrate potential for significant \nfuture breakthroughs in the understanding of the pathogensis, \ndiagnosis, and treatment of Parkinson's. Grants under this subsection \nshall be available for a period of not to exceed 5 years.\n    ``(e) Authorization of Appropriations.--For the purpose of carrying \nout this section, there are authorized to be appropriated $100,000,000 \nfor fiscal year 1998, and such sums as may be necessary for each of the \nfiscal years 1999 and 2000.\n    ``(f) Limitation on Use of Certain Funds of Public Health \nService.--Notwithstanding any other provision of law, none of the \namounts made available under this Act may be expended for any research \nthat uses human fetal tissue, cells, or organs obtained from a living \nor dead human embryo or fetus during or after an induced abortion, or \nfor any therapeutic application for Parkinson's that uses such human \nfetal tissue, cells, or organs. This subsection does not apply to human \nfetal tissue, cells, or organs obtained from a spontaneous abortion or \nan ectopic pregnancy.''."
}